Facebook
X
LinkedIn
Forward| Title | Credit |
Start and expiration dates |
Member price | Non-member price |
|---|---|---|---|---|
|
2026 Pediatric Pharmacology Update 1.00 NAPNAP contact hour of which 1.00 pharmacology content. This continuing education activity is offered as part of the Pediatric Pharmacology Bundle. This course is a record presentation for NAPNAP's 2026 National Conference. There are almost daily changes affecting pediatric prescribing with newly approved or relabeled pediatric medications and pediatric pharmacology studies in process. This presentation will discuss issues that affect pediatric practice, including drug shortages, emerging poisoning hazards and new guidelines. |
|
07/01/2026 to 06/30/2028 | $0.00 | $0.00 |
|
Pharmacogenomics: Emerging trends in pediatric personalized medicine 1.25 NAPNAP contact hours of which 1.25 pharmacology content. This continuing education activity is offered as part of the Pediatric Pharmacology Bundle. This course is a record presentation for NAPNAP's 2026 National Conference. Pharmacogenomics, the science of evaluating the effects of genetic variants on one's response to treatment, allows for delivery of personalized medicine in pediatric patients. Emerging trends in pediatrics for pharmacogenomic testing include cardiology, asthma, cystic fibrosis, leukemias, rheumatologic disorders and more. The use of pharmacogenomic testing in mental health disorders has widely been described elsewhere. |
|
07/01/2026 to 06/30/2028 | $0.00 | $0.00 |
|
Pediatric Psychopharmacology Update 2026 1.00 NAPNAP contact hour of which 1.00 pharmacology content, 1.00 psychopharmacology content and 0.25 controlled substance content. This continuing education activity is offered as part of the Pediatric Pharmacology Bundle. This course is a record presentation for NAPNAP's 2026 National Conference. Evidence shows that pediatric primary and specialty care providers are often challenged by the management of pediatric patients with mental and behavioral health conditions. This presentation provides an update on recent advances in pediatric psychopharmacology, focusing on the safe and effective use of psychiatric medications in children and adolescents. With an emphasis on evidence-based treatment strategies, we will review updated guidelines, emerging research on medication use and newly approved medications for use in pediatrics. Special attention will be given to the management of attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorder (ASD), including the use of stimulants, non-stimulant ADHD medications, and SSRIs. We will also address strategies to enhance adherence and monitoring and challenges faced when choosing specific agents, including tips for dealing with the complexities of obtaining prior authorizations.. Participants will gain practical insights to optimize pharmacologic treatment plans within an integrated, patient-centered approach to improve pediatric mental health care. |
|
07/01/2026 to 06/30/2028 | $0.00 | $0.00 |
|
What Are You Taking? Hot Topics in Herbal Supplementations 1.25 NAPNAP contact hours of which 0.5 pharmacology content. This continuing education activity is offered as part of the Pediatric Pharmacology Bundle. This course is a record presentation for NAPNAP's 2026 National Conference. About a third of all children ingest some type of supplementations most being multivitamins and this number is increasing. Social media has provided avenues to learn and experiment with supplements. Only five percent of patients discuss supplements with a provider prior to starting. This presentation will provide guidance on resources for providers to use for supplementation education and review common supplements that might be used in pediatrics. |
|
07/01/2026 to 06/30/2028 | $0.00 | $0.00 |
|
When Healing Means Letting Go: A Perspective on Deprescribing Antidepressants 1.00 NAPNAP contact hour of which 0.5 pharmacology content, and 0.5 psychopharmacology content. This continuing education activity is offered as part of the Pediatric Pharmacology Bundle. This course is a record presentation for NAPNAP's 2026 National Conference. Approximately 12% of Americans take an antidepressant. Traditional guidance has been to taper these medications over a few weeks and that withdrawal symptoms will be brief and mild. However, the reality experienced by many patients is quite different. This presentation will discuss common withdrawal symptoms, how to differentiate withdrawal from relapse, and hyperbolic tapering - an emerging method which can reduce withdrawal intensity and support safer discontinuation of these medications. |
|
07/01/2026 to 06/30/2028 | $0.00 | $0.00 |
|
Itching, Sneezing, Coughing, Wheezing- New Pharmacology for the troublesome symptoms of Pediatric Allergy! 1.00 NAPNAP contact hour of which 1.00 pharmacology content. This continuing education activity is offered as part of the Pediatric Pharmacology Bundle. This course is a record presentation for NAPNAP's 2026 National Conference. This lively review of pediatric allergy will discuss the newest medications for anaphylaxis, allergic rhinitis, atopic dermatitis and asthma. We will explore the newest immunotherapy treatments as they enhance desensitization. |
|
07/01/2026 to 06/30/2028 | $0.00 | $0.00 |
|
2026 National Conference on Pediatric Health Care Bundle Customize your learning...choose five courses from NAPNAP's 2026 National Conference from a list of 13 courses. This continuing education activity is offered at a member-only discounted rate of $45. Non-members may purchase this bundle for $90. |
07/01/2026 to 07/01/2028 | $45.00 | $45.00 |